Breast cancer: Clinical practice guidelines in oncology Journal Article
| Authors: | Carlson, R. W.; Anderson, B. O.; Burstein, H. J.; Cox, C. E.; Edge, S. B.; Farrar, W. B.; Goldstein, L. J.; Gradishar, W. J.; Hayes, D. F.; Hudis, C.; Jahanzeb, M.; Ljung, B. M.; Marks, L. B.; McCormick, B.; Nabell, L. M.; Pierce, L. J.; Reed, E. C.; Silver, S. M.; Smith, M. L.; Somlo, G.; Theriault, R. L.; Ward, J. H.; Winer, E. P.; Wolff, A. C. |
| Article Title: | Breast cancer: Clinical practice guidelines in oncology |
| Abstract: | The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment, but also to contribute to improving the treatment of future patients. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | review; doxorubicin; fluorouracil; area under the curve; dose response; multimodality cancer therapy; antineoplastic agents; capecitabine; gemcitabine; paclitaxel; adjuvant therapy; combined modality therapy; radiotherapy, adjuvant; chemotherapy; methotrexate; cancer staging; antineoplastic agent; neoplasm staging; clinical practice; carboplatin; breast cancer; mastectomy; tumor markers, biological; nccn clinical practice guidelines; cyclophosphamide; practice guideline; breast neoplasms; tumor marker; docetaxel; cancer invasion; mammography; conservative treatment; breast tumor; carcinoma in situ; recurrent disease; epirubicin; radiation therapy; hormonal therapy; cancer epidemiology; trastuzumab; navelbine; endocrine therapy; ductal carcinoma in situ; lobular carcinoma in situ; breast-conserving therapy |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 3 |
| Issue: | 3 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2005-05-01 |
| Start Page: | 238 |
| End Page: | 289 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 38" - "Export Date: 24 October 2012" - "Source: Scopus" |
